parabilis – Lab DB

Pharmaceutical R&D

Regeneron Pharmaceuticals and Parabilis Medicines Forge Landmark $2.32 Billion Collaboration to Pioneer a New Era of Intracellular Therapies

Teuku Ryan May 20, 2026 0

Regeneron Pharmaceuticals has announced a monumental research collaboration with Parabilis Medicines, a deal valued at an impressive $2.32 billion. This…

Regeneron Pharmaceuticals and Parabilis Medicines Forge Landmark $2.32 Billion Collaboration to Pioneer a New Era of Intracellular Therapies

YOU MAY HAVE MISSED

Unlocking the Secrets of Senescent Cells: DNA Aptamers Offer a Breakthrough in Aging and Disease Research

TWiV 1289: Building a Better Hepatitis B Trap

Investigating the causes of rheumatoid arthritis pain

Scientists warn that current vitamin B12 guidelines may be putting your brain at risk